n-Butylidenephthalide recovered calcium homeostasis to ameliorate neurodegeneration of motor neurons derived from amyotrophic lateral sclerosis iPSCs
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0311573 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Yu-Chen Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical and Molecular Medical Sciences, National Dong Hwa University, Hualien, Taiwan. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Induced Pluripotent Stem Cells, Motor Neurons, Calcium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council of Taiwan, Hualien Tzu Chi Hospital.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that causes muscle atrophy and primarily targets motor neurons (MNs). Approximately 20% of familial ALS cases are caused by gain-of-function mutations in superoxide dismutase 1 (SOD1), leading to MN degeneration and ion channel dysfunction. Previous studies have shown that n-Butylidenephthalide (BP) delays disease progression and prolongs survival in animal models of ALS. However, no studies have been conducted on models from human sources. Herein, we examined the protective efficacy of BP on MNs derived from induced pluripotent stem cells (iPSCs) of an ALS patient harboring the SOD1 G85R mutation as well as on those derived from genetically corrected iPSCs (SOD1 G85G ). Our results demonstrated that the motor neurons differentiated from iPSC with SOD1 G85R mutation exhibited characteristics of neuron degeneration (as indicated by the reduction of neurofilament expression) and ion channel dysfunction (in response to potassium chloride (KCl) and L-glutamate stimulation), in contrast to those derived from the gene corrected iPSC (SOD1 G85G ). Meanwhile, BP treatment effectively restored calcium ion channel function by reducing the expression of glutamate receptors including glutamate ionotropic receptor AMPA type subunit 3 (GluR3) and glutamate ionotropic receptor NMDA type subunit 1 (NMDAR1). Additionally, BP treatment activated autophagic pathway to attenuate neuron degeneration. Overall, this study supports the therapeutic effects of BP on ALS patient-derived neuron cells, and suggests that BP may be a promising candidate for future drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemical and Molecular Medical Sciences, National Dong Hwa University, Hualien, Taiwan.
- Everfront Biotech Inc., Taipei, Taiwan.
- Bioinnovation Center, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
- Department of Pathology, Hualien Tzu Chi Hospital, Hualien, Taiwan.
- Department of Neurosurgery, Hualien Tzu Chi Hospital, Hualien, Taiwan.
- Department of Nursing, Tzu Chi University of Science and Technology, Hualien, Taiwan.
ORCID-Profile: Yu-Chen Deng, Shinn-Zong Lin
Förderung
- National Science and Technology Council of Taiwan
- Hualien Tzu Chi Hospital
Zitieren
APA
Deng, Y. C., Liu, J. W., Ting, H. C., Kuo, T. C., Chiang, C. H., Lin, E. Y., Harn, H. J., Lin, S. Z., Chang, C. Y., & Chiou, T. W. (2024). n-Butylidenephthalide recovered calcium homeostasis to ameliorate neurodegeneration of motor neurons derived from amyotrophic lateral sclerosis iPSCs. PLOS ONE. https://doi.org/10.1371/journal.pone.0311573
Vancouver
Deng YC, Liu JW, Ting HC, Kuo TC, Chiang CH, Lin EY, et al. n-Butylidenephthalide recovered calcium homeostasis to ameliorate neurodegeneration of motor neurons derived from amyotrophic lateral sclerosis iPSCs. PLOS ONE. 2024. doi:10.1371/journal.pone.0311573
BibTeX
@article{Deng2024,
author = {Deng, Yu-Chen and Liu, Jen-Wei and Ting, Hsiao-Chien and Kuo, Tzu-Chen and Chiang, Chia-Hung and Lin, En-Yi and Harn, Horng-Jyh and Lin, Shinn-Zong and Chang, Chia-Yu and Chiou, Tzyy-Wen},
title = {n-Butylidenephthalide recovered calcium homeostasis to ameliorate neurodegeneration of motor neurons derived from amyotrophic lateral sclerosis iPSCs},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0311573}
}
EUVIMED